Should journals publish industry-funded bioethics articles?

Lancet

Volumn 366, Issue 9483, 2005, Pages 422-424

  Elliott, Carl ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DRUG INDUSTRY; HEALTH CARE; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL; SHORT SURVEY;

EID: 23044437099     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66794-3     Document Type: Note

References (30)

1. C Elliott Pharma buys a conscience Am Prospect 12 2001 16
2. S Stolberg Bioethicists find themselves the ones being scrutinized NY Times (New York) A1 Aug 2, 2001
3. T Lemmens, B Freedman Ethics review for sale? Conflict of interest and commercial research review boards Milbank Q 78 2000 547 584
4. TL Beauchamp, B Jennings, ED Kinney, RJ Levine Pharmaceutical research involving the homeless J Med Philos 27 2002 547 564
5. PA Singer, AS Daar Harnessing genomics and biotechnology to improve global health equity Science 294 2001 87 89
6. MM Mendiola, T Peters, EW Young, L Zoloth-Dorfman Research with human embryonic stem cells: ethical considerations. By Geron Ethics Advisory Board Hastings Cent Rep 29 1999 31 36
7. DS Charney, CB Nemeroff, L Lewis National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders Arch Gen Psychiatry 59 2002 262 270
8. RP Lanza, AL Caplan, LM Silver, JB Cibelli, MD West, RM Green The ethical validity of using nuclear transfer in human transplantation JAMA 284 2000 3175 3179
9. Perspect Biol Med 48 suppl 1 2005
10. D Katz, AL Caplan, JF Merz All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving Am J Bioeth 3 2003 39 46
11. S Okie AMA criticized for letting drug firms pay for ethics campaign Washington Post (Washington, DC) A03 August 30, 2001
12. Working group of the Advisory Commitee to the Director Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies http://www.nih.gov/about/ethics_COI_panelreport.pdf (accessed April 26, 2005)
13. B Brody, N Dubler, J Blustein Bioethics consultation in the private sector Hastings Cent Rep 32 2002 14 20
14. LA Jansen, DP Sulmasy Bioethics, conflicts of interest and the limits of transparency Hastings Cent Rep 33 2003 40 43
15. M Schroeder Some professors take payments to express views Wall Street Journal (New York) B1 Dec 10, 2004
16. J Weil Insurance hazard: booking agency sought speakers to criticize Spitzer Wall Street Journal (New York) C3 Oct 29, 2004
17. D Hanners Documents indicate tobacco industry paid scientists to write to editors Aug 5, 1998 St Paul Pioneer Press MN, USA
18. S Krimsky, LS Rothenberg Conflict of interest policies in science and medical journals: editorial practices and author disclosures Sci Eng Ethics 7 2001 205 218
19. Center for Science in the Public Interest CSPI calls for prevention and disclosure of conflicts of interest in bioethics http://www.cspinet.org/new/ bioethics_061102.html (accessed April 26, 2005)
20. B Als-Nielsen, W Chen, C Gluud, LL Kjaergard Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290 2003 921 928
21. MM Chren, CS Landefeld Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary JAMA 271 1994 684 689
22. M Angell The truth about the drug companies 2004 Random House New York
23. S Hensley Drug firms shown classroom door - continuing-ed programs for doctors aim to reduce influence of big companies Wall Street Journal (New York) D5 Jan 14, 2003
24. R Moynihan Drug company sponsorship of education could be replaced at a fraction of its cost BMJ 326 2003 1163
25. B Burton, A Rowell Unhealthy spin BMJ 326 2003 1205 1207
26. L Payer Disease-mongers: how doctors, drug companies, and insurers are making you feel sick 1992 J Wiley New York
27. A Relman Separating continuing medical education from pharmaceutical marketing JAMA 285 2001 2009 2012
28. The Washington Post Washington Post Standards and Ethics http://www.asne.org/ideas/codes/washingtonpost.htm (accessed April 26, 2005)
29. J Drazen, G Curfman Financial associations of authors N Engl J Med 346 2002 1901 1902
30. J Kassirer On the take 2004 Oxford University Press New York